E Giovannucci

Author PubWeight™ 176.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998 6.50
2 Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993 6.37
3 Epidemic influenza and vitamin D. Epidemiol Infect 2006 5.32
4 Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 1999 5.27
5 Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals. Epidemiology 1996 4.37
6 Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 2001 4.30
7 Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA 1996 4.29
8 Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am J Clin Nutr 1999 3.89
9 Recreational physical activity and the risk of cholecystectomy in women. N Engl J Med 1999 3.82
10 Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol 1995 3.76
11 Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997 3.36
12 A prospective study of social networks in relation to total mortality and cardiovascular disease in men in the USA. J Epidemiol Community Health 1996 3.28
13 Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999 3.22
14 Alcohol intake in relation to diet and obesity in women and men. Am J Clin Nutr 1991 3.20
15 Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998 2.97
16 A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer 2005 2.62
17 Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts. Am J Clin Nutr 2000 2.61
18 Adiposity and mortality in men. Am J Epidemiol 2000 2.60
19 Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst 1996 2.58
20 Coffee, caffeine, and cardiovascular disease in men. N Engl J Med 1990 2.49
21 Leisure-time physical activity, body size, and colon cancer in women. Nurses' Health Study Research Group. J Natl Cancer Inst 1997 2.46
22 A prospective study of parental history of myocardial infarction and coronary artery disease in men. Am J Cardiol 1991 2.45
23 Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 1999 2.30
24 Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994 2.10
25 A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 1996 2.03
26 Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Intern Med 1998 1.96
27 Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J Natl Cancer Inst 2001 1.90
28 Diet and basal cell carcinoma of the skin in a prospective cohort of men. Am J Clin Nutr 2000 1.85
29 Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III). Int J Obes (Lond) 2005 1.82
30 Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes Control 2000 1.82
31 Effectiveness of various mailing strategies among nonrespondents in a prospective cohort study. Am J Epidemiol 1990 1.78
32 Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia. Am J Epidemiol 1999 1.73
33 Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J Natl Cancer Inst 2000 1.72
34 Benefit-risk assessment of vitamin D supplementation. Osteoporos Int 2009 1.70
35 A prospective study of whole-grain intake and risk of type 2 diabetes mellitus in US women. Am J Public Health 2000 1.68
36 A prospective study on intake of animal products and risk of prostate cancer. Cancer Causes Control 2001 1.62
37 Incidence rates and risk factors for acute urinary retention: the health professionals followup study. J Urol 1999 1.58
38 Estimating the global and regional burden of suboptimal nutrition on chronic disease: methods and inputs to the analysis. Eur J Clin Nutr 2011 1.54
39 Harvard Report on Cancer Prevention. Volume 3: prevention of colon cancer in the United States. Cancer Causes Control 1999 1.51
40 A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men. JAMA 1999 1.51
41 Predictors of dietary heterocyclic amine intake in three prospective cohorts. Cancer Epidemiol Biomarkers Prev 1998 1.49
42 Body weight and colorectal cancer risk in a cohort of Swedish women: relation varies by age and cancer site. Br J Cancer 2001 1.49
43 Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev 2000 1.43
44 Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol Biomarkers Prev 1998 1.39
45 Whole grain consumption and risk of colorectal cancer: a population-based cohort of 60,000 women. Br J Cancer 2005 1.39
46 Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men. Am J Epidemiol 1996 1.37
47 Blood donations and risk of coronary heart disease in men. Circulation 2001 1.36
48 High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia. Am J Med 1998 1.32
49 A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1999 1.31
50 Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men. Cancer Epidemiol Biomarkers Prev 1999 1.30
51 Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men. J Natl Cancer Inst 2001 1.29
52 Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomarkers Prev 2001 1.28
53 Physical activity and benign prostatic hyperplasia. Arch Intern Med 1998 1.27
54 Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men. Am J Epidemiol 2000 1.26
55 Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden) Cancer Causes Control 1998 1.25
56 Diet, alcohol, and smoking and the occurrence of hyperplastic polyps of the colon and rectum (United States). Cancer Causes Control 1995 1.25
57 Energy, nutrient intake and prostate cancer risk: a population-based case-control study in Sweden. Int J Cancer 1996 1.24
58 Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies. Br J Cancer 2010 1.19
59 Calcium, vitamin D, dairy foods, and the occurrence of colorectal adenomas among men and women in two prospective studies. Am J Epidemiol 1994 1.19
60 A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 1997 1.18
61 Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study. J Urol 2000 1.16
62 Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. Ann Intern Med 1999 1.16
63 A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma. Carcinogenesis 1998 1.15
64 Glycosylated hemoglobin and risk of colorectal cancer and adenoma (United States). Cancer Causes Control 1999 1.08
65 Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis. Br J Cancer 2011 1.07
66 Risk factors for basal cell carcinoma of the skin in men: results from the health professionals follow-up study. Am J Epidemiol 1999 1.01
67 Distinction between symptoms of voiding and filling in benign prostatic hyperplasia: findings from the Health Professionals Follow-up Study. Urology 1998 1.01
68 Dietary fiber and distal colorectal adenoma in men. Cancer Epidemiol Biomarkers Prev 1997 1.00
69 A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men. Growth Horm IGF Res 2000 1.00
70 Cholecystectomy and the risk for developing colorectal cancer and distal colorectal adenomas. Br J Cancer 2003 0.99
71 Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer. Br J Cancer 2010 0.99
72 Dietary glycemic index, glycemic load, insulin index, fiber and whole-grain intake in relation to risk of prostate cancer. Cancer Causes Control 2010 0.98
73 Gallstones, cholecystectomy, and the risk for developing pancreatic cancer. Br J Cancer 2002 0.98
74 The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol 2001 0.98
75 Diet, nutrition, and prostate cancer. Annu Rev Nutr 1998 0.98
76 Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden. Br J Cancer 2006 0.95
77 Aspirin use and lung cancer in men. Br J Cancer 2003 0.95
78 A prospective study of lifetime physical activity and prostate cancer incidence and mortality. Br J Cancer 2009 0.94
79 Retrospective analysis of birth weight and prostate cancer in the Health Professionals Follow-up Study. Am J Epidemiol 1998 0.94
80 Toenail selenium concentrations and bladder cancer risk in women and men. Br J Cancer 2005 0.92
81 Risk of bladder cancer by geographic region in a U.S. cohort of male health professionals. Epidemiology 2001 0.92
82 Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma. Br J Cancer 2006 0.90
83 Parity and other reproductive factors and risk of adenomatous polyps of the distal colorectum (United States). Cancer Causes Control 1997 0.90
84 Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: epidemiological studies. Growth Horm IGF Res 2000 0.90
85 The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer. Cancer Epidemiol Biomarkers Prev 2001 0.90
86 Vasectomy and prostate cancer: a case-control study in India. Int J Epidemiol 1997 0.89
87 The V89L polymorphism in the 5alpha-reductase type 2 gene and risk of prostate cancer. Cancer Res 1999 0.89
88 A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis. Cancer Epidemiol Biomarkers Prev 1997 0.88
89 The androgen receptor gene GGN microsatellite and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 1998 0.86
90 Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3. J Am Acad Dermatol 2000 0.86
91 Gamma-tocopherol: a new player in prostate cancer prevention? J Natl Cancer Inst 2000 0.85
92 The androgen receptor CAG repeat polymorphism and its relationship to prostate cancer. Biochim Biophys Acta 1998 0.85
93 Gonorrhoea and male bladder cancer in a prospective study. Br J Cancer 2006 0.85
94 No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev 2000 0.84
95 PTEN polymorphism (IVS4) is not associated with risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2001 0.82
96 One-carbon metabolism factors and endometrial cancer risk. Br J Cancer 2013 0.80
97 Prospective analysis of vitamin D and endometrial cancer risk. Ann Oncol 2012 0.79
98 Plasma steroid hormones, surgery for benign prostatic hyperplasia, and severe lower urinary tract symptoms. Prostate Cancer Prostatic Dis 1999 0.79
99 Mixed blessings for middle-aged mothers. Nature 1997 0.78
100 Diet and the prevention of cancer. Cancer Metastasis Rev 1998 0.78
101 Fruit and vegetable consumption and colorectal cancer incidence. IARC Sci Publ 2002 0.77
102 Dietary mutagens and the risk of breast cancer. J Natl Cancer Inst 1998 0.77
103 Cancer mortality rates in Menofeia, Egypt: comparison with US mortality rates. Cancer Causes Control 1999 0.76
104 The impact of different therapies on symptoms of benign prostatic hyperplasia: a prospective study. Clin Ther 1997 0.75
105 Debrisoquine hydroxylase (CYP2D6) and prostate cancer. Cancer Epidemiol Biomarkers Prev 1998 0.75